|
|
|
| Research progress on inappropriate medication use in the elderly |
| ZHAO Liyan1 ZHAO Zhongpeng2 CHENG Yanqin1 LI Mingchun1 |
1.Department of Pharmacy, the 401st Hospital of PLA, Shandong Province, Qingdao 266071, China;
2.Institute of Microbiology and Epidemiology, Academy of Military Sciences, Beijing 100086, China |
|
|
|
Abstract Older people are more likely to have adverse drug events (ADE) due to their decreased physiological function and often have multiple underlying diseases. ADE may manifest as one or more syndromes of the elderly, including falls, convulsions, dizziness, incontinence, sleep disorders, etc., seriously affecting the life and behavioral abilities of the elderly, while giving harder for diagnosis and treatment. Identification and early intervention of inappropriate medication use in the elderly are important for reducing the risk of medication, avoiding and reducing ADE. In recent years, the research focuses on the potential inappropriate medication (PIM) use standards for the elderly, multiple drug use and medcation reconciliation, and PIM prevention, this article reviews these three aspects.
|
|
|
|
|
|
[1] 韩烁.人口老龄化对医疗费用的影响研究[D].长春：吉林大学，2018：2-8.
[2] 孙建勋，周秋霞，岳淑梅.我国老年群体慢性病患病状况及药学服务需求调查[J].中国药学杂志，2016，51（2）：155-158.
[3] Beers MH. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine [J]. Arch Intern Med，1991，151（9）：1825-1832.
[4] Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update [J]. Arch Intern Med，1997，157（14）：1531-1536.
[5] Updating the Beers criteria for potentially inappropriate medication use in older adults：results of a US consensus panel of experts [J]. Arch Intern Med，2003，163（22）：3716-3724.
[6] American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults [J]. J Am Geriatr Soc，2012，60（4）：616-631.
[7] American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults [J]. J Am Geriatr Soc，2015，63（11）：2227-2246.
[8] American Geriatrics Society 2019 updated AGS Beers criteria?誖 for potentially inappropriate medication use in older adults [J]. J Am Geriatr Soc，2019，67：674-694.
[9] O′Mahony D，O′Sullivan D，Byrne S，et al. STOPP/START criteria for potentially inappropriate prescribing in older people：version 2 [J]. Age and Ageing，2015，44：213-218.
[10] 梁华玉，王育琴，邱雨婕，等.美国老年医学会2015 版老年人潜在不适当用药Beers标准简介[J].药物不良反应杂志，2016，18（1）：52-59.
[11] Chang CB，Yang SY，Lai HY，et al. Using published criteria to develop a list of potentially inappropriate medications for elderly patients in Taiwan [J]. Pharmacoepidemiol Drug Safety，2012，21：1269-1279.
[12] 中国老年保健医学研究会合理用药分会，中华医学会老年医学分会等.中国老年人潜在不适当用药判断标准（2017版）[J].药物不良反应杂志，2018，20（1）：2-8.
[13] 闫妍，王育琴，沈芊，等.中国老年人潜在不适当用药目录的研制[J].药物不良反应杂志，2015，17（1）：19-26.
[14] 张晓琳，周双，周颖，等.老年人不适当用药的研究进展[J].中华老年医学杂志，2018，37（4）：479-484.
[15] 侯凯旋，邢晓璇，闫素英.老年人潜在不适当用药研究概况[J].实用药物与临床，2018，21（2）：206-211.
[16] 侯凯旋，邢晓璇，闫素英.基于新版Beers和STOPP标准的内科病区老年住院患者潜在不适当用药情况分析[J].药物不良反应杂志，2018，20（4）：276-283.
[17] Hedna K，Hakkarainen KM，Gyllensten H，et al. Potentially inappropriate prescribing and adverse drug reactions in the elderly：a population- based study [J]. Eur J Clin Pharmacol，2015，71（12）：1525-1533.
[18] Muhlack DC，Hoppe LK，Weberpalsa J，et al. The association of potentially inappropriate medication at older age with cardiovascular events and overall mortality：a systematic review and Meta-analysis of cohort studies [J].Jamda，2017，18（3）：211-220.
[19] 中国老年保健医学研究会老年内分泌与代谢病分会，中国毒理学会临床毒理专业委员会.老年人多重用药安全管理专家共识[J].中国糖尿病杂志，2018，26（9）：705-718.
[20] Campbell NL，Perkins AJ，Bradt P，et al. Associationof anticholinergic burden with cognitive impairment and health care utilizationamong a diverse ambulatory older adult population [J]. Pharmacotherapy，2016，36（11）：1123-1131.
[21] Rudolph JL，Salow MJ，Angelini MC，et al. Theanticholinergic risk scale and anticholinergic adverse effects in olderpersons [J]. Arch Intern Med，2008，168（5）：508-513.
[22] Campbell N，Boustani M，Limbil T，et al. The cognitiveimpact of anticholinergics：a clinical review [J]. Clin Interv Aging，2009（4）：225-233.
[23] O′Connor MN，Gallagher P，O′Mahony D. Inappropriate prescribing：criteria，detection and prevention [J]. Drugs Aging，2012，29（6）：437-452.
[24] 广东省药学会.药源性（抗胆碱能）认知功能障碍健康管理共识[N].今日药学，2018-10-26.
[25] Adam JR，Shira HF，Michael KPO. Beyond medication reconciliation. The correct medication list [J]. JAMA，2017， 317（20）：2057-2058.
[26] Carnahan RM，Lund BC，Perry PJ，et al. Theanticholinergic drug scale as a measure of drug-related anticholinergic burden：association with serum anticholinergic activity [J]. J Clin Pharmacol，2006，46：1481-1486.
[27] Rudolph JL，Salow MJ，Angelini MC，et al. Theanticholinergic risk scale and anticholinergic adverse effects in olderpersons [J]. Arch Intern Med，2008，168（5）：508-513.
[28] Boustani MA，Campbell N，Munger S，et al. Impact ofanticholinergics on the aging brain：a review and practical application [J]. Aging Health，2008，4（3）：311-320.
[29] 李兵，李彦，聂坤，等.胆碱能系统功能紊乱与帕金森病轻度认知功能障碍研究进展[J].中华老年心脑血管病杂志，2017，19（6）：659-661.
[30] 闫雪莲，韩爽，梅丹，等.老年科住院患者药物重整中药师的作用[J].临床药物治疗杂志，2017，15（12）：19-22.
[31] Manias E，Kusljic S，Lam DL. Use of the screening tool of older persons′ prescriptions（STOPP） and the screening tool to alert doctors to the right treatment（START） in hospitalized older people [J]. Australas J Ageing，2015， 34（4）：252-258.
[32] Li Hong，Pu Shiyun，Liu Qinhui，et al. Potentially inappropriate medications in Chinese older adults：the beers criteria compared with the screening tool of older persons′ prescriptions criteria [J]. Geriatr Gerontol Int，2017， 17（11）：1951-1958.
[33] 李影影，玉晶，王烨，等.Beers标准和STOPP/START标准再评价老年住院患者医嘱点评情况[J].药学与临床研究，2016，24（1）：57-60. |
|
|
|
